My bookmarksSign up free
Source

Commission Implementing Decision (EU) 2016/1049 of 27 June 2016 establishing the financial contribution from the Union for expenditure incurred by Cyprus in 2013 for the financing of the emergency measures to combat Newcastle disease (notified under document C(2016) 3857)

Commission Implementing Decision (EU) 2016/1049 of 27 June 2016 establishing the financial contribution from the Union for expenditure incurred by Cyprus in 2013 for the financing of the emergency measures to combat Newcastle disease (notified under document C(2016) 3857)

Implementing Decision (EU) 2016/1049 · Decision · 2 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

1.   The financial contribution from the Union towards the expenditure incurred by Cyprus in 2013 for the financing of emergency measures to combat Newcastle disease is hereby fixed at EUR 274 204,69. 2.   The balance of the financial contribution from the Union remaining to be paid to Cyprus is hereby fixed at EUR 24 204,69.

Other acts of the same type
Council Decision (CFSP) 2024/418 of 29 January 2024 amending Decision (CFSP) 2020/1999 concerning restrictive measures against serious human rights violations and abusesCouncil Decision (CFSP) 2024/421 of 29 January 2024 amending Decision 2011/72/CFSP concerning restrictive measures directed against certain persons and entities in view of the situation in TunisiaCouncil Decision (CFSP) 2024/422 of 29 January 2024 amending Decision 2014/512/CFSP concerning restrictive measures in view of Russia’s actions destabilising the situation in UkraineCouncil Decision (EU) 2024/435 of 29 January 2024 on the position to be adopted on behalf of the European Union within the CETA Joint Committee established under the Comprehensive Economic and Trade Agreement (CETA) between Canada, of the one part, and the European Union and its Member States, of the other part, as regards the adoption of an Interpretation of Article 8.10, Annex 8-A, Article 8.9 and Article 8.39 thereof in accordance with its Article 26.1.5(e)Council Decision (EU) 2024/444 of 29 January 2024 establishing the position to be taken on behalf of the European Union in the World Trade Organization’s 13th Ministerial Conference as regards the incorporation of the Agreement on Investment Facilitation for Development into the Agreement Establishing the World Trade OrganizationCouncil Decision (EU) 2024/447 of 29 January 2024 on the signing, on behalf of the Union, of the Agreement between the European Union and the Republic of Armenia on the cooperation between the European Union Agency for Criminal Justice Cooperation (Eurojust) and the authorities of the Republic of Armenia competent for judicial cooperation in criminal mattersDecision (EU) 2024/461 of the European Central Bank of 29 January 2024 on the reporting by national competent authorities to the European Central Bank of information on remuneration, gender pay gap, approved higher ratios and high earners for the purposes of benchmarking (ECB/2024/2)Council Decision (EU) 2024/578 of 29 January 2024 on the signing, on behalf of the Union, of the Protocol amending the Agreement between the European Union and Japan for an Economic PartnershipCouncil Decision (EU) 2024/2780 of 29 January 2024 on the position to be taken on behalf of the European Union at the third session of the Meeting of the Parties to the Protocol to Eliminate Illicit Trade in Tobacco ProductsCommission Implementing Decision (EU) 2024/388 of 26 January 2024 amending Implementing Decision (EU) 2021/1385 as regards the scope extension of the authorisation and repealing Implementing Decision (EU) 2015/701Commission Implementing Decision (EU) 2024/389 of 26 January 2024 renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified oilseed rape Ms8, Rf3 and Ms8 × Rf3 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (notified under document C(2024) 432)Commission Implementing Decision (EU) 2024/391 of 26 January 2024 authorising the placing on the market of products containing, consisting of or produced from genetically modified maize Bt11 × MIR162 × MIR604 × MON 89034 × 5307 × GA21 and thirty sub-combinations, pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (notified under document C(2024) 434)

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next

Browse all EU Legal ActsEvery instrument by type and year, full text free to read section by sectionEuropean Union legislationEU Legal Acts by type and yearGrouped by instrument type and year of enactment, so you can find others of the same kindBrowse by type and yearEuropean Union: what this database coversWhich datasets are here, which official source they come from, and how current they areEuropean Union overview